|
||||
|
Last week → Inside week one of the rescheduling hearing |
||||
| Headlines this week | ||||
The record is closing — and the opposition's own witness conceded Schedule III. |
||||
|
The DEA rescheduling hearing's second week produced the proceeding's most consequential moment: under cross-examination by DEA counsel on July 6, Smart Approaches to Marijuana's key witness, Harvard Medical School psychiatry professor Dr. Bertha Madras, acknowledged that marijuana meets the statutory criteria for Schedule III under the Controlled Substances Act. The opposition's counter-case continued regardless — pain physician Kenneth Finn testified July 8 that state medical programs don't operate under modern-medicine standards, citing 18 of 27 randomized trials showing no benefit — and the hearing ran ahead of schedule, recessing July 9 before the Tennessee Bureau of Investigation presented July 10. Two participants remain: pharmacist Phillip Drum today, and the states of Nebraska, Idaho, Indiana and Louisiana tomorrow. The record closes no later than Wednesday, July 15. Then the waiting begins: an ALJ recommendation, a final rule, and near-certain litigation. Operators should keep §280E reserves intact — nothing changes until a rule takes effect. |
||||
| This week at a glance | ||||
|
Top story. The DEA rescheduling hearing enters its final days with the opposition's star witness having conceded, under cross, that marijuana fits Schedule III's statutory definition. Final testimony runs through July 14; the record closes by July 15. Next three.
|
||||
| Federal & agency desk | ||||
|
The hearing's turning point: SAM's witness concedes the Schedule III criteria
Why it matters: The concession goes to the heart of the case. When the opposition's own expert acknowledges marijuana meets the Schedule III statutory definition, the evidentiary record tilts toward the government's position — and it is that record the ALJ recommendation, the final rule, and every appeal will rest on. Keep §280E reserves intact; a concession is not a ruling. Under DEA cross-examination July 6, Dr. Bertha Madras — Harvard Medical School psychiatry professor and Smart Approaches to Marijuana's key witness — acknowledged marijuana meets the CSA's Schedule III criteria. Kenneth Finn, M.D. followed July 8, arguing state medical programs are not medicine and citing 18 of 27 RCTs showing no benefit. The hearing recessed July 9 (ahead of schedule), resumed with the Tennessee Bureau of Investigation July 10, and closes by July 15 after Phillip Drum (July 13) and four states (July 14). | ||||
|
NIST publishes the federal playbook for cannabis scales
Why it matters: Weights-and-measures rules are a quiet compliance surface — dispensaries get cited over scale certification more often than over labeling in some states. A NIST analysis gives state regulators a common technical baseline; expect state requirements to converge on it. Retailers should ask their scale vendors whether current equipment matches the report's recommendations. The National Institute of Standards and Technology published a report to help state regulators "develop a set of requirements for scales used in the sale of Cannabis products, based on scientific analysis," noting cannabis has distinct properties from traditional commodities subject to weights-and-measures regulation. Sources: Marijuana Moment
| ||||
|
Major banking group presses Congress on cannabis financial services
Why it matters: Banking access remains the industry's most persistent operational tax, and a major banking trade group lobbying for it matters more than industry groups doing the same — banks are the constituency Congress listens to on banking bills. No floor action is scheduled; treat this as pressure, not progress. A major banking trade group urged Congress to pass legislation easing marijuana businesses' access to financial services. Details on timing still emerging. Sources: Marijuana Moment
| ||||
| Statehouse roundup | ||||
|
Massachusetts — legalization rollback measure qualifies for the November ballot
Why it matters: No state has ever reversed adult-use legalization at the ballot box; Massachusetts will now test that. Operators in the state face four months of campaign uncertainty over licenses, employment, and inventory value. Multistate operators should scenario-plan; the CCC's regulatory posture between now and November bears watching. The Secretary of the Commonwealth's Office certified that an initiative to roll back the state's marijuana legalization law submitted enough valid signatures — "but just barely" — to appear on the November 2026 ballot. Sources: Marijuana Moment
| ||||
|
Virginia — an accidental-repeal scramble, an August 15 hemp cap, and open rulemaking
Why it matters: Virginia is running three compliance clocks at once. The hard one: August 15, when products over 2 mg total THC per package can no longer be produced or sold as hemp in the commonwealth — multistate brands shipping into Virginia should rescope SKUs now. The soft ones: the CCA's retail rulemaking survey is open ahead of the July 2027 launch, and the penalty question makes enforcement posture unpredictable. Treat current penalties as enforceable; talk to your counsel. Lawmakers and police are working to clarify whether unclear enactment clauses in the retail-legalization law inadvertently repealed marijuana penalties for a year — details still emerging. Separately, hemp oversight has moved from VDACS to the Cannabis Control Authority, the 2 mg per-package total-THC cap takes effect August 15, and the CCA launched a public survey to inform retail-market rules. | ||||
|
North Carolina — Senate adopts the hemp/kratom compromise; House vote waits until late July
Why it matters: The conference text is now public and it is the stricter path: a 0.4 mg total-THC-per-container cap aligned to the November 12 federal standard, a synthetic-cannabinoid ban, and 21+ age-gating on hemp consumables and kratom. If the House concurs, NC's THCA flower market — one of the country's largest — shrinks sharply. Operators have a window to model inventory and exit plans before the House acts. The Senate adopted the HB 328 conference report 37-6 on July 2; the House is expected to take it up the week of July 27. Not yet law. Meanwhile, Gov. Josh Stein reiterated support for legalization while House Speaker Destin Hall said his caucus has "no interest in doing any sort of marijuana, medicinal or otherwise" — a signal that a regulated-marijuana offramp is not coming. | ||||
|
Illinois — IDFPR tells dispensaries how to use their new powers
Why it matters: The omnibus signed last month is now operational guidance: doubled possession limits, drive-thru windows, and expanded hours are live compliance questions, not statutory abstractions. Illinois licensees should review the guidance before modifying storefronts or POS limits — the details determine what needs prior approval. The Department of Financial and Professional Regulation published guidance for licensed cannabis businesses on the newly increased possession limits and the ability to add drive-thru windows and expand operating hours. Sources: Marijuana Moment
| ||||
|
Enforcement watch — Woodward, Oklahoma: five illegal grows shut down as federal pesticide charges land
Why it matters: Oklahoma's medical market is under coordinated pressure from both sovereigns in the same week — the state AG's organized-crime task force on unlicensed operations, and federal prosecutors on illegal foreign pesticides at a licensed farm. Licensed operators should treat pesticide sourcing records as an enforcement exposure, not just an agronomy question. The Oklahoma attorney general's Organized Crime Task Force announced it shut down five illegal marijuana operations in Woodward. Separately, federal prosecutors in the Eastern District of Oklahoma indicted employees of a Seminole County marijuana farm on charges relating to illegal foreign pesticides. Sources: Oklahoma AG · DOJ (E.D. Okla.)
| ||||
| International desk | ||||
|
Thailand — Bhumjaithai files the medical-only bill
Why it matters: Thailand's 2022 decriminalization built a retail cannabis economy that its own architects are now dismantling. A formal bill restricting cannabis to medical use is the concrete legislative vehicle operators have been waiting to see — anyone with Thai retail exposure should track the bill's committee path and stop underwriting expansion against the status quo. A Bhumjaithai party lawmaker filed a cannabis control bill that would restrict legal cannabis to medical use, the latest step in the government's multi-year re-tightening of the 2022 framework. Sources: Bangkok Post
| ||||
|
Mexico — health regulators to comply with the Supreme Court on personal-use permits
Why it matters: COFEPRIS agreeing to comply with the court's unconstitutionality ruling removes the administrative blockade on personal-use permits — a procedural step, but one that re-opens the question of when Mexico's stalled regulatory framework moves. Commercial rules remain absent; this is a consumer-rights development, not a market opening. Mexican health officials said they will comply with a Supreme Court ruling on the unconstitutionality of the ban on recreational marijuana use, clearing the way for personal-use permits. Sources: Milenio
| ||||
| From our database | ||||
|
First complete state legality database
Every cannabinoid. Every state. One database.
Recreational, medical, THCA, Delta-8, Delta-9, HHC, CBD, and more — cross-referenced across all 50 states plus DC and Puerto Rico. Updated as laws move. The only single source operators can use to scope multi-state compliance before drafting product, packaging, or shipping policy. Open the state laws database → |
||||
| Need help with anything in this brief? | ||||
|
Two ways to get answers — instant AI for interpretation questions, or a real attorney for matters that need counsel. |
||||
| One thing to read | ||||
|
With the hearing record closing Wednesday, the question shifts from testimony to consequences. Our Schedule III compliance playbook covers what a reclassification would and would not change — §280E relief mechanics, DEA registration, and the traps in between. Read the summary → |
How useful was this week's brief?
Reach the people who write the compliance checks.
The Regulator Brief goes out every Monday to cannabis attorneys, compliance officers, and licensed operators across US states and international jurisdictions. If you want to put your product in front of them, get in touch.
Know someone who'd benefit from this?
Forward it, or use your personal link below. Refer three colleagues and we'll send you our 50-state cannabis legality reference PDF.
Speak naturally. Send without fixing.
Wispr Flow turns your voice into clean, professional text you can send the moment you stop talking. Not rough transcription you have to clean up. Actual polished text — ready for email, Slack, or any app.
Speak the way you think. Go on tangents. Change your mind mid-sentence. Flow strips the filler, fixes the grammar, and gives you text that reads like you spent five minutes writing it.
89% of messages sent with zero edits. Millions of professionals use Flow daily, including teams at OpenAI, Vercel, and Clay. Works on Mac, Windows, and iPhone.

